- EGFR Wildtype
- Non-small Cell Lung Cancer Metastatic
- Non-small cell lung cancer, stage III
- Adenocarcinoma of Lung
The study aims to explore the prevalence of ALK/ROS1/MET mutations assessed with ctDNA samples in EGFR-wildtype NSCLC
We have no "publications" for this trial. Help us by contributing data.